page_banner

Substratbenetzungs- und Anti-Krater-Additive

Silikon -Benetzungsmittel/Silikon -Tensid SL - 3245

Kurzbeschreibung:

WynCoat® Like all surfactants, a substrate wetting additive is a molecule having both a hydrophilic and a hydrophobic part. The additive’s molecular structure determines that the orientation will drastically lower the surface tension of the liquid. Wetting additives provide multifunctional benefits in a range of applications including inks and coatings. SL-3245 optimize flow and leveling, enable the elimination of surface defects and reduce surface tension.

SL - 3245 entspricht Tego - 245 in internationalen Märkten.



Produktdetail

Produkt -Tags

Produktdetails

WynCoat® SL-3245 wetting and anti-crater additive that can help paint or ink wetting above the surface of a variety of substrates, even on a low surface energy substrate to prevent shrinkage and uneven surfaces defects. 

Schlüsselmerkmale und Vorteile

It is silicone surfactant for waterborne and solvent-borne formulation. It provides powerful reduction in surface tension which leads to excellent substrate wetting, leveling and anti-crater. It does not increase surface slip and does not impair recoatability. 

Typische Daten

• Appearance: pale-yellow colored clear liquid. (becomes hazy and thickness at temperatures below 15 ℃,returns to clear and pourable after warming)

• Active matter content: 100%

• Viscosity at 25 ℃:60-100cst

Nutzungsniveaus (additiv wie geliefert)

• Automotive coatings: 0.2-1.0%

• Coatings for plastics: 0.2-1.0%

• Industrial coatings: 0.2-1.0%

• Wood and furniture coatings: 0.2-1.0%

• Architectural coatings: 0.2-1.0%

• Decorative coatings: 0.2-1.0%

• Inkjet inks: 0.2-1.0%

• Leather pre-primers, primers and top coats based on polyurethane, acrylic, nitrocellulose and casein binders: 0.2-1.0%

Paket- und Speicherstabilität

Erhältlich in 25 kg Eimer und 200 kg Trommeln.

24 months in closed containers. 

Einschränkungen

Dieses Produkt wird weder getestet noch als geeignet für medizinische oder pharmazeutische Anwendungen dargestellt.


  • Vorherige:
  • Nächste:


    • Vorherige:
    • Nächste: